Satsuki Mikuriya
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Satsuki Mikuriya has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Hirotaka Sakamoto
Department of Biology, Faculty of Environmental, Life, Natural Science and Technology Okayama University Okayama Japan
1 shared publication Kaori Tanaka
Division of Transcriptomics, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan
1 shared publicationKazuhide Inoue
Kyushu University Institute for Advanced Study, Fukuoka, Japan
1 shared publication- Keiko Takanami
School of Life Science, The Graduate University for Advanced Studies
1 shared publication - Keita Kohno
Department of Molecular and System Pharmacology, Graduate School of Pharmaceutical Sciences, Kyushu University
1 shared publication Kohei Yoshihara
Department of Molecular and System Pharmacology, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan
1 shared publication
Latest Publications
- Top Cited Papers
- 1 April 2022
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 376 (6588) , 86-90
A spinal microglia population involved in remitting and relapsing neuropathic pain
Neuropathic pain is often caused by injury and diseases that affect the somatosensory system. Although pain development has been well studied, pain recovery mechanisms remain largely unknown. Here, we found that CD11c-expressing spinal microglia appear after the development of behavioral pain hypersensitivity following nerve injury. Nerve-injured mice with spinal CD11c + microglial depletion failed to recover spontaneously from this hypersensitivity. CD11c + microglia expressed insulin-like growth factor-1 (IGF1), and interference with IGF1 signaling recapitulated the impairment in pain recovery. In pain-recovered mice, the depletion of CD11c + microglia or the interruption of IGF1 signaling resulted in a relapse in pain hypersensitivity. Our findings reveal a mechanism for the remission and recurrence of neuropathic pain, providing potential targets for therapeutic strategies.
- 1 April 2022
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 376 (6588) , 86-90
Top Cited PapersA spinal microglia population involved in remitting and relapsing neuropathic pain
Neuropathic pain is often caused by injury and diseases that affect the somatosensory system. Although pain development has been well studied, pain recovery mechanisms remain largely unknown. Here, we found that CD11c-expressing spinal microglia appear after the development of behavioral pain hypersensitivity following nerve injury. Nerve-injured mice with spinal CD11c + microglial depletion failed to recover spontaneously from this hypersensitivity. CD11c + microglia expressed insulin-like growth factor-1 (IGF1), and interference with IGF1 signaling recapitulated the impairment in pain recovery. In pain-recovered mice, the depletion of CD11c + microglia or the interruption of IGF1 signaling resulted in a relapse in pain hypersensitivity. Our findings reveal a mechanism for the remission and recurrence of neuropathic pain, providing potential targets for therapeutic strategies.